GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Medical Services Holdings Ltd (NYSE:CCM) » Definitions » 12-1 Month Momentum %

Concord Medical Services Holdings (Concord Medical Services Holdings) 12-1 Month Momentum % : -54.37% (As of Apr. 29, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Concord Medical Services Holdings 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-29), Concord Medical Services Holdings's 12-1 Month Momentum % is -54.37%.

The industry rank for Concord Medical Services Holdings's 12-1 Month Momentum % or its related term are showing as below:

CCM's 12-1 Month Momentum % is ranked worse than
87.69% of 642 companies
in the Healthcare Providers & Services industry
Industry Median: -11.705 vs CCM: -54.37

Competitive Comparison of Concord Medical Services Holdings's 12-1 Month Momentum %

For the Medical Care Facilities subindustry, Concord Medical Services Holdings's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Concord Medical Services Holdings's 12-1 Month Momentum % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Concord Medical Services Holdings's 12-1 Month Momentum % falls into.



Concord Medical Services Holdings  (NYSE:CCM) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Medical Services Holdings  (NYSE:CCM) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Concord Medical Services Holdings 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Concord Medical Services Holdings's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Medical Services Holdings (Concord Medical Services Holdings) Business Description

Traded in Other Exchanges
N/A
Address
Room 2701-05 , 36 North Third Ring Road, Tower A, Global Trade Center, Dongcheng District, Beijing, CHN, 100013
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers and diagnostic imaging centers and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.